ELISA:OMXHEXElisa Oyj Class A Analysis
Data as of 2026-08-08 - not real-time
€35.14
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Elisa Oyj trades at €35.14, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 5.3%. RSI sits at 44.5, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at €33.70 up to resistance at €37.30.
Valuation screens as fair: a P/E of 16.5 sits in line with the sector average of 16.1. Consensus targets land 14.6% above where the shares trade now. The 6.83% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 26.3%, a beta of -0.02 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Valuation screens as fair: a P/E of 16.5 sits in line with the sector average of 16.1. Consensus targets land 14.6% above where the shares trade now. The 6.83% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 26.3%, a beta of -0.02 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 39.40
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 16.5 versus sector average of 16.1
- Trading below the 200-day average of 39.40
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 16.5 versus sector average of 16.1
- Analyst targets imply +14.6% versus the current price
- Profit margin of 15.2% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-0.30%
Profit Margin15.22%
P/E Ratio16.5
ROE28.13%
ROA8.49%
Debt/Equity119.00
P/B Ratio4.2
Op. Cash Flow€653.2M
Free Cash Flow€133.9M
Industry P/E16.1
Technical Analysis
TrendBearish
RSI44.5
Support€33.70
Resistance€37.30
MA 20€35.18
MA 50€36.98
MA 200€39.40
MACDBullish
VolumeDecreasing
Fear & Greed Index94.82
Valuation
Fair Value€1.44
Target Price€40.28
Upside/Downside14.64%
GradeFair
TypeBlend
Dividend Yield6.83%
Risk Assessment
Beta-0.02
Volatility26.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.